Search Results - Jonathan Goldin
- Showing 1 - 10 results of 10
-
1
Minimum clinically important difference in Quantitative Lung Fibrosis score associated with all-cause mortality in idiopathic pulmonary fibrosis: subanalysis from two phase II tria... by Matthew S Brown, Jonathan Goldin, Grace Hyun Kim, Xueping Zhang, Lona Poole
Published in BMJ Open (2025-05-01)Get full text
Article -
2
-
3
Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy by Elizabeth R. Volkmann, Holly Wilhalme, Shervin Assassi, Grace Hyun J. Kim, Jonathan Goldin, Masataka Kuwana, Donald P. Tashkin, Michael D. Roth
Published in ACR Open Rheumatology (2023-10-01)Get full text
Article -
4
Quantitative image analysis in COVID-19 acute respiratory distress syndrome: a cohort observational study. [version 3; peer review: 2 approved] by Grace Hyun J Kim, Dale Jun, Bianca Villagas, Tamas Dolinay, Jonathan Goldin, Brandon Grimes, Augustine Chung, David Nelson, Lillian Hsu, Abigail Maller
Published in F1000Research (2023-03-01)Get full text
Article -
5
An analysis of the regional heterogeneity in tissue elasticity in lung cancer patients with COPD by Michael Lauria, Bradley Stiehl, Anand Santhanam, Dylan O’Connell, Louise Naumann, Michael McNitt-Gray, Ann Raldow, Jonathan Goldin, Igor Barjaktarevic, Daniel A. Low
Published in Frontiers in Medicine (2023-09-01)Get full text
Article -
6
Extent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO registry by Aparna C. Swaminathan, Jeremy M. Weber, Jamie L. Todd, Scott M. Palmer, Megan L. Neely, Timothy P. Whelan, Grace Hyun J. Kim, Thomas B. Leonard, Jonathan Goldin
Published in Respiratory Research (2025-02-01)Get full text
Article -
7
Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and II by Elizabeth R. Volkmann, Virginia Steen, Ning Li, Michael D. Roth, Philip J. Clements, Daniel E. Furst, Shervin Assassi, Dinesh Khanna, Grace‐Hyun J. Kim, Jonathan Goldin, Robert M. Elashoff, Donald P. Tashkin
Published in ACR Open Rheumatology (2021-01-01)Get full text
Article -
8
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease. by Viktor Martyanov, Grace-Hyun J Kim, Wendy Hayes, Shuyan Du, Bishu J Ganguly, Oumar Sy, Sun Ku Lee, Galina S Bogatkevich, Gary L Schieven, Elena Schiopu, Roberta Gonçalves Marangoni, Jonathan Goldin, Michael L Whitfield, John Varga
Published in PLoS ONE (2017-01-01)Get full text
Article -
9
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung... by Donald P Tashkin, Rohit Aggarwal, Chester V Oddis, Grace Kim, Fereidoun Abtin, Daniela Markovic, Christina Charles-Schoeman, Galina Marder, Jonathan Goldin, Paul F Dellaripa, Swamy Venuturupalli, Gary Matt Hunninghake, Tracy J Doyle, Siamak Moghadam-Kia, Sangmee Sharon Bae, Cato Chan, Daniel Sullivan, Jeremy Falk
Published in RMD Open (2024-11-01)Get full text
Article -
10
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF study by Lisa Lancaster, Vincent Cottin, Murali Ramaswamy, Wim A. Wuyts, R. Gisli Jenkins, Mary Beth Scholand, Michael Kreuter, Claudia Valenzuela, Christopher J. Ryerson, Jonathan Goldin, Grace Hyun J. Kim, Marzena Jurek, Martin Decaris, Annie Clark, Scott M. Turner, Chris N. Barnes, Hardean E. Achneck, Gregory P. Cosgrove, Éric A. Lefebvre, Kevin R. Flaherty
Published in Therapeutic Advances in Respiratory Disease (2024-11-01)Get full text
Article